Project Grant R01AG094076
- Federal Grant Award Summary Grant Details: The National Institute on Aging (NIA) awarded a Project Grant totaling $3,424,229 to the University of California, Davis on September 15, 2025, under the Aging Research program (CFDA 93.866). The project, with a completion date of September 14, 2029, addresses critical gaps in understanding the relationship between social health and cognitive decline in Alzheimer's disease and related dementias (AD/ADRDS). Deliverables and Research Objectives: The...
- Federal Grant Award Summary The National Institute on Aging awarded the University of California, Irvine a $3.22 million Project Grant under the Aging Research program (CFDA 93.866) on September 15, 2025, with a completion date of August 31, 2029. This research initiative examines the role of the retrosplenial cortex (RSC) in Alzheimer's disease (AD) pathogenesis through translational investigation combining mouse models and human studies. The primary deliverables include scientific findings...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded a $5.16 million Project Grant to the University of California, Davis for research under the Aging Research program (CFDA 93.866), effective September 1, 2025 through August 31, 2029. This research initiative examines the relationship between environmental exposures and brain health, particularly as they relate to Alzheimer's disease and related dementias (ADRD). The project will deliver empirical research...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $336,000 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded September 1, 2025, with completion targeted for August 31, 2027. This research initiative evaluates the utility of self-reported subjective cognitive concerns (SCC) as an early screening tool for Alzheimer's disease (AD) by examining their relationship with longitudinal AD biomarkers in a diverse...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded $147,486 to University of California, Berkeley under the Aging Research program (CFDA 93.866) on May 26, 2025 for a two-year project completing May 25, 2027. The award funds a comprehensive research study examining the influence of social network cognitive buffers (SNCBs)—comprising both objective and subjective dimensions of social interaction—on cognitive aging and their potential relationship to Alzheimer's...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded $127,224 to the University of California, San Diego on October 24, 2025, under the Aging Research program (CFDA 93.866) to support scientific investigation into the pathological mechanisms of Alzheimer's disease (AD). The project, which extends through August 31, 2028, will elucidate the role of s-nitrosylated phospholipase D3 (SNO-PLD3) in microglial and neuronal pathophysiology associated with AD. Specifically,...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded $4.59 million to The Regents of the University of California, San Francisco under the Aging Research program (CFDA 93.866) for a project titled "Digital Speech Markers for Early Detection of Alzheimer's Disease in a Longitudinal Racially and Ethnically Diverse Cohort." The award, effective September 5, 2025, through August 31, 2029, funds research to develop and validate an automated speech analysis...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded the University of California, Berkeley a $1,079,604 Project Grant on May 15, 2025, under the Aging Research program (CFDA 93.866) to conduct research on heterogeneous causal pathophysiology in Alzheimer's disease (AD). The primary deliverables include the development of novel statistical methodologies for causal discovery that will identify population-specific pathophysiological pathways underlying AD progression....
- Federal Grant Award Summary S-3 Research LLC received a $999,556 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) awarded on September 20, 2025, with a completion date of September 19, 2026. The company is developing a multi-modal digital tool designed to improve diversity and inclusivity in Alzheimer's Disease and Related Dementias (ADRD) clinical trial participation. The deliverable consists of an integrated platform incorporating mobile...
- Federal Project Grant Award Summary The National Institute on Aging awarded UC San Diego a $165,488 Project Grant (CFDA 93.866, Aging Research program) effective March 1, 2026, through November 30, 2028, to develop artificial intelligence-driven biomarker identification for reducing misdiagnosis in Alzheimer's disease. The project addresses the critical challenge of AD misdiagnosis rates reaching 25%, which result in inappropriate treatments in 18-67% of cases and undermine research reliability....
The National Institute on Aging (NIA) awarded a Project Grant of $690,934 to the University of California, Davis, with an award date of March 1, 2026, and completion date of November 30, 2030, under the Aging Research program (CFDA 93.866). This research project addresses subjective cognitive decline (SCD) as an early indicator of Alzheimer's Disease and Related Dementias (AD/ADRD) across diverse racial and ethnic populations. The research will examine how SCD—self-perceived cognitive decline occurring in the context of normal cognitive test performance—relates to the development of mild cognitive impairment, dementia, and AD/ADRD biomarkers, with particular emphasis on identifying which SCD characteristics (including SCD-associated worry and worsening complaints over time) most reliably signal preclinical disease risk. This project directly addresses a critical knowledge gap in existing SCD research, which has been predominantly focused on white older adults despite documented disparities in dementia risk among Black and Latino older adults. The deliverables include research findings on how SCD is expressed and progresses differently across cultural, racial, and ethnic groups, and identification of validated predictive features that can enable scalable, sensitive approaches to identifying individuals at increased AD/ADRD risk. These research outputs will inform prevention strategies and disease-modifying treatment initiatives for diverse aging populations at disproportionate risk for cognitive decline and dementia.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $690.9k | 2/19/26 |